Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-24

Clinical Trial Update: Decreasing Depression and Anxiety and Their Effect on QoL of ESRD Patients (End-Stage Renal Disease) [NA]

View source ↗

Summary

ClinicalTrials.gov entry describing an ongoing study on whether decreasing depression and anxiety improves quality of life in patients with End-Stage Renal Dise…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hospital Civil de Guadalajara | Conditions: End-Stage Renal Disease | NA | Status: UNKNOWN